Albuquerque clinical pharmacist Charles “Kurt” Mahan specializes in antithrombotic therapy and venous thromboembolism (VTE) prevention.
VTE, which is a blood clot that starts in a vein, is the third leading vascular diagnosis after heart attack and stroke.
For his work, Mahan, who grew up in Clovis, has been awarded the 2019 Dorothy Dillon Award.
The award is granted to those who have made “significant contributions to health-system pharmacy in the form of sustained exemplary service in health-system pharmacy or a combination of accomplishments benefiting health-system pharmacy.”
The previous three recipients of the Dillon award select the current winner.
Mahan, who graduated from Clovis High School in 1989, is a clinical pharmacist at Presbyterian Hospital in Albuquerque.
He received his Bachelor of Science/doctorate in pharmacy from the University of New Mexico, where he also serves as a clinical assistant professor of pharmacy.
In 2006, he served as the Director of Pharmacy at Lovelace Healthcare, where he worked on VTE quality measure development.
He has published five book chapters and almost 30 peer-reviewed articles, primarily of original research.
He is currently involved as an investigator in several studies in the field.